Zhang Jun Zheng Ltd - Net Worth and Insider Trading

Zhang Jun Zheng Ltd Net Worth

The estimated net worth of Zhang Jun Zheng Ltd is at least $176 Million dollars as of 2025-07-19. Zhang Jun Zheng Ltd is the 2501 Other of Immunotech Biopharm Ltd and owns about 41,691,428 shares of Immunotech Biopharm Ltd (HKSE:06978) stock worth over $176 Million. Details can be seen in Zhang Jun Zheng Ltd's Latest Holdings Summary section.

Disclaimer: The insider information is derived from SEC filings. The estimated net worth is based on the final shares held after open market or private purchases and sales of common stock with a transaction code of "P" or "S" on Form 4, assuming that Zhang Jun Zheng Ltd has not made any transactions after 2020-07-10 and currently still holds the listed stock(s). Please note that this estimate may not reflect the actual net worth.

Transaction Summary of Zhang Jun Zheng Ltd

Zhang Jun Zheng Ltd Insider Ownership Reports

Based on ownership reports from SEC filings, as the reporting owner, Zhang Jun Zheng Ltd owns 1 companies in total, including Immunotech Biopharm Ltd (HKSE:06978) .

Click here to see the complete history of Zhang Jun Zheng Ltd’s form 4 insider trades.

Insider Ownership Summary of Zhang Jun Zheng Ltd

Ticker	Company	Transaction Date	Type of Owner
HKSE:06978	Immunotech Biopharm Ltd	2020-07-10	2501 Other

Zhang Jun Zheng Ltd Latest Holdings Summary

Zhang Jun Zheng Ltd currently owns a total of 1 stock. Zhang Jun Zheng Ltd owns 41,691,428 shares of Immunotech Biopharm Ltd (HKSE:06978) as of July 10, 2020, with a value of $176 Million.

Latest Holdings of Zhang Jun Zheng Ltd

Ticker	Company	Latest Transaction Date	Shares Owned	Current Price ($)	Current Value ($)
HKSE:06978	Immunotech Biopharm Ltd	2020-07-10	41,691,428	4.22	175,937,826

Holding Weightings of Zhang Jun Zheng Ltd

Zhang Jun Zheng Ltd Form 4 Trading Tracker

According to the SEC Form 4 filings, Zhang Jun Zheng Ltd has made a total of 0 transactions in Immunotech Biopharm Ltd (HKSE:06978) over the past 5 years. The most-recent trade in Immunotech Biopharm Ltd is the sale of 41,691,428 shares on July 10, 2020, which brought Zhang Jun Zheng Ltd around $0.

Insider Trading History of Zhang Jun Zheng Ltd

No transactions are available. GuruFocus only tracks and displays the purchase and sale of non-derivative security in open market or private transactions from SEC filings with the transaction code of P or S.

Total 0

Only the transactions in Open Market or Private Sale at the market prices are included. Other transactions such as conversion of derivative security or exercise of options are not included. Insiders are limited to only officers and/or directors of the company.

Zhang Jun Zheng Ltd Trading Performance

Please note GuruFocus will not track the insiders’ transaction performance if he/she does not have buying transactions.

Zhang Jun Zheng Ltd Ownership Network

Ownership Network List of Zhang Jun Zheng Ltd

No Data

Ownership Network Relation of Zhang Jun Zheng Ltd

Zhang Jun Zheng Ltd Owned Company Details

What does Immunotech Biopharm Ltd do?

Who are the key executives at Immunotech Biopharm Ltd?

Zhang Jun Zheng Ltd is the 2501 Other of Immunotech Biopharm Ltd. Other key executives at Immunotech Biopharm Ltd include 2201 Interest of corporation controlled by you jia ze hong ye tian jin ke ji you xian gong si , 2101 Beneficial owner Jiaze Global Capital Limited , and 2101 Beneficial owner xi zang jia ze chuang ye tou zi you xian gong si .

Immunotech Biopharm Ltd (HKSE:06978) Insider Trades Summary

Over the past 18 months, Zhang Jun Zheng Ltd made no insider transaction in Immunotech Biopharm Ltd (HKSE:06978). Other recent insider transactions involving Immunotech Biopharm Ltd (HKSE:06978) include a net sale of 0 shares made by Jung Hyun Chul , a net sale of 0 shares made by Evodevo Ltd , and a net sale of 0 shares made by Cao Longxiang .

In summary, during the past 3 months, insiders sold 0 shares of Immunotech Biopharm Ltd (HKSE:06978) in total and bought 0 shares, with a net sale of 0 shares. During the past 18 months, 0 shares of Immunotech Biopharm Ltd (HKSE:06978) were sold and 0 shares were bought by its insiders, resulting in a net sale of 0 shares.

Immunotech Biopharm Ltd (HKSE:06978)'s detailed insider trading history can be found in Insider Trading Tracker table.

Immunotech Biopharm Ltd Insider Transactions

No Available Data

Zhang Jun Zheng Ltd Mailing Address

Above is the net worth, insider trading, and ownership report for Zhang Jun Zheng Ltd. Currently GuruFocus does not have mailing address information for Zhang Jun Zheng Ltd.

Research Tools

All-In-One Screener Stock Ideas Stock List Guru List Guru Real-Time Picks Insider List Insider Trades Economic Indicators Sector & Industry Performance DCF Calculator Discussion Board

Product

Pricing Plans Excel Add-In Google Sheets Add-on Data API Stock Comparison Table Manual of Stocks Instant Alerts Mobile App 中文

Education

Financial Glossary Tutorials FAQ Schedule Free Session Buffett Indicator Shiller P/E Yield Curve Today U.S. Inflation Rate Global Market Valuation Fed Net Liquidity Buffett Assets Allocation

Company

About GuruFocus Career Contact Us Advertise Term of Use Privacy Policy Referral Program Partner Program

Survey

We'd love to learn more about your experiences on GuruFocus.com and how we can improve!

Take Survey

Disclaimers

GuruFocus.com is not operated by a broker or a dealer. Under no circumstances does any information posted on GuruFocus.com represent a recommendation to buy or sell a security. The information on this site, and in its related newsletters, is not intended to be, nor does it constitute investment advice or recommendations. The individuals or entities selected as "gurus" may buy and sell securities before and after any particular article and report and information herein is published, with respect to the securities discussed in any article and report posted herein. Gurus may be added or dropped from the GuruFocus site at any time. In no event shall GuruFocus.com be liable to any member, guest or third party for any damages of any kind arising out of the use of any content or other material published or available on GuruFocus.com, or relating to the use of, or inability to use, GuruFocus.com or any content, including, without limitation, any investment losses, lost profits, lost opportunity, special, incidental, indirect, consequential or punitive damages. Past performance is a poor indicator of future performance. The information on this site, and in its related newsletters, is not intended to be, nor does it constitute investment advice or recommendations. The information on this site is in no way guaranteed for completeness, accuracy or in any other way. The gurus listed in this website are not affiliated with GuruFocus.com, LLC. Stock quotes are provided by QuoteMedia, Inc. (CSI). Company fundamental data is provided by Morningstar. Analyst estimates data is sourced from both Refinitiv and Morningstar, with priority given to Refinitiv data. Data is updated daily.